BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23289836)

  • 1. Response to Treglia et al.
    Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
    Thyroid; 2013 Jan; 23(1):126-7. PubMed ID: 23289836
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to stack et Al.
    Hegedüs L; Soelberg KK; Brix TH; Bonnema SJ
    Thyroid; 2013 May; 23(5):637-8. PubMed ID: 23470012
    [No Abstract]   [Full Text] [Related]  

  • 3. Focal thyroid uptake on 18F-fluorodeoxyglucose positron emission tomography: interpreting the data.
    Stack BC; Bodenner DL; Bartel TB; Boeckmann J
    Thyroid; 2013 May; 23(5):636-7. PubMed ID: 23281924
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and risk of malignancy of thyroid incidentalomas detected by (18)f-fluorodeoxyglucose positron-emission tomography.
    Treglia G; Giovanella L; Bertagna F; Di Franco D; Salvatori M
    Thyroid; 2013 Jan; 23(1):124-6. PubMed ID: 23289835
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
    Sharma SD; Jacques T; Smith S; Watters G
    J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it possible to predict malignancy in cases with focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography?
    Fujii T; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
    Am Surg; 2012 Jan; 78(1):141-3. PubMed ID: 22273333
    [No Abstract]   [Full Text] [Related]  

  • 7. Focal thyroid incidental uptake detected by ¹⁸F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk.
    Treglia G; Bertagna F; Sadeghi R; Verburg FA; Ceriani L; Giovanella L
    Nuklearmedizin; 2013; 52(4):130-6. PubMed ID: 23765102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-associated incidental neoplasms of the thyroid.
    Katz SC; Shaha A
    J Am Coll Surg; 2008 Aug; 207(2):259-64. PubMed ID: 18656056
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
    Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
    Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
    King DL; Stack BC; Spring PM; Walker R; Bodenner DL
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):400-4. PubMed ID: 17765765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic strategy of incidental findings of focal thyroid FDG uptake identified on PET/CT].
    Nielsen MH; Nygaard B; Søndergaard SB; Bennedbæk FN
    Ugeskr Laeger; 2011 Aug; 173(33):1948-52. PubMed ID: 21849133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose-avid parathyroid adenoma mimicking thyroid incidentaloma.
    Huang TS; Lee JJ; Lin YC; Cheng SP
    ANZ J Surg; 2010 Oct; 80(10):763-4. PubMed ID: 21040351
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of BRAF mutation and SUV
    Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
    Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F18-FDG-PET/CT thyroid incidentalomas and their benign or malignant nature: a critical and debated issue.
    Bertagna F; Giubbini R
    Ann Nucl Med; 2011 Feb; 25(2):151-2. PubMed ID: 21104345
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a role for fluorine-18 fluorodeoxyglucose positron emission tomography imaging in medullary thyroid cancer?
    Kauhanen S; Schalin-Jäntti C
    Endocrine; 2012 Dec; 42(3):461-3. PubMed ID: 22798248
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
    Wong C; Lin M; Chicco A; Benson R
    Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas.
    Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR
    Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
    Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
    [No Abstract]   [Full Text] [Related]  

  • 19. The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study: A Systematic Review and Meta-analysis.
    Nayan S; Ramakrishna J; Gupta MK
    Otolaryngol Head Neck Surg; 2014 Aug; 151(2):190-200. PubMed ID: 24759908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases.
    Kim MS; Sim YS; Lee SY; Jeon DG
    Ann Nucl Med; 2007 Nov; 21(9):529-32. PubMed ID: 18030586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.